EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Fatty Acids for the Treatment of Ocular Diseases and Ocular Drug Delivery

Guihua Fang, Bo Tang iD, Jiayan Yin

Molecular Pharmaceutics · 02.11.2026 · 23 (11) · 5197-5215

DOI: 10.1021/acs.molpharmaceut.6c00705 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 18.10.2026. Verfasst von Guihua Fang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nantong University, Nantong, Jiangsu Province 226001, China. Hauptthemen laut MEDLINE: Fatty Acids, Eye Diseases, Drug Delivery Systems. Die Arbeit nennt 156 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intricate anatomical and physiological barriers of the eye severely limit the bioavailability of conventional topical therapies, necessitating innovative strategies. In this review, fatty acids are presented as versatile agents functioning in two distinct roles. As bioactive lipids, specific fatty acids exert disease-modifying effects, offering novel pharmacological interventions for ocular surface and posterior segment disorders, including dry eye syndrome, uveitis, and retinal degeneration. Concurrently, beyond their biological activity, fatty acids serve as structural components in formulation design; their physicochemical properties, particularly varying chain lengths and degrees of unsaturation, enable the construction of advanced ocular drug delivery systems with substantially enhanced ocular bioavailability. Crucially, this review not only summarizes the translational prospects of fatty acid-based therapeutics but also highlights the structure−activity relationships governing the in vivo performance of fatty acid-integrated delivery systems. By delineating these dual functionalities, we provide a clear framework for distinguishing nutritional or pharmacological supplementation from excipient or carrier design, thereby facilitating the rational development of next-generation ophthalmic formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty AcidsEye DiseasesDrug Delivery SystemsHumansAnimalsBiological AvailabilityAdministration, OphthalmicOphthalmic SolutionsStructure-Activity Relationship

Stichwörter der Autor:innen

eyefatty acidsocular diseasesocular drug delivery systems

Substanzen

Fatty AcidsOphthalmic Solutions

Autor:innen und Institutionen

  • School of Pharmacy, Nantong University, Nantong, Jiangsu Province 226001, China.

ORCID-Profile: Bo Tang

Förderung

  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Fang, G., Tang, B., & Yin, J. (2026). Fatty Acids for the Treatment of Ocular Diseases and Ocular Drug Delivery. Molecular Pharmaceutics, 23(11), 5197-5215. https://doi.org/10.1021/acs.molpharmaceut.6c00705

Vancouver

Fang G, Tang B, Yin J. Fatty Acids for the Treatment of Ocular Diseases and Ocular Drug Delivery. Molecular Pharmaceutics. 2026;23(11):5197-5215. doi:10.1021/acs.molpharmaceut.6c00705

BibTeX
@article{Fang2026,
  author = {Fang, Guihua and Tang, Bo and Yin, Jiayan},
  title = {Fatty Acids for the Treatment of Ocular Diseases and Ocular Drug Delivery},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {11},
  pages = {5197--5215},
  doi = {10.1021/acs.molpharmaceut.6c00705}
}
Kostenlos starten →